Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series.

Name: Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series.
Author: Ishii, Satoshi

Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series. — المؤلف: Ishii, Satoshi — Journal of clinical medicine research Mar 2019

المؤلف: Ishii, Satoshi
النشر: Journal of clinical medicine research Mar 2019
الوصف: 219-224 p.